Yang Xu-Min, Yang Xu-Yan, Wang Xin-Yu, Gu Yue-Xia
Department of Nursing, The First Affiliated Hospital of Naval Medical University (Changhai Hospital), Shanghai 200433, China.
Department of Thyroid, Breast and Vascular Surgery, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200434, China.
World J Gastrointest Oncol. 2024 Mar 15;16(3):810-818. doi: 10.4251/wjgo.v16.i3.810.
Hepatocellular carcinoma (HCC) is a prevalent malignancy, and transcatheter arterial embolization (TAE) has emerged as a pivotal therapeutic modality. However, TAE may induce symptom distress and fatigue, adversely affecting the quality of life of patients.
To investigate symptom distress, fatigue, and associated factors in HCC patients undergoing TAE.
We used a cross-sectional design and purposive sampling to enroll HCC patients who underwent TAE at our institution from January to December 2022. Questionnaires were utilized to collect data on symptom distress and fatigue scores from the first to the third day after TAE.
Our study revealed a significant reduction in fatigue and symptom distress among patients after TAE. Pain, fatigue, insomnia, fever and abdominal distension were the most common symptoms troubling patients during the first 3 d post-TAE. Marital status, presence of family support, physical functional status, age, and symptom distress were identified as predictors of fatigue in patients.
Healthcare professionals should educate HCC patients on symptom distress and fatigue, offering personalized relief strategies to lessen their psychological burden.
肝细胞癌（HCC）是一种常见的恶性肿瘤，经导管动脉栓塞术（TAE）已成为一种关键的治疗方式。然而，TAE可能会引发症状困扰和疲劳，对患者的生活质量产生不利影响。
调查接受TAE的HCC患者的症状困扰、疲劳及相关因素。
我们采用横断面设计和目的抽样法，纳入了2022年1月至12月在我院接受TAE的HCC患者。通过问卷调查收集TAE后第一天至第三天的症状困扰和疲劳评分数据。
我们的研究显示，TAE后患者的疲劳和症状困扰显著减轻。疼痛、疲劳、失眠、发热和腹胀是TAE后前3天困扰患者的最常见症状。婚姻状况、家庭支持情况、身体功能状态、年龄和症状困扰被确定为患者疲劳的预测因素。
医护人员应向HCC患者宣传症状困扰和疲劳的相关知识，提供个性化的缓解策略，以减轻他们的心理负担。
